Whole Shine Medical Technology Co (SZSE:002622) Debt-to-Equity : 1.12 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Whole Shine Medical Technology Co Debt-to-Equity?

Whole Shine Medical Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥333.5 Mil. Whole Shine Medical Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥149.6 Mil. Whole Shine Medical Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥431.5 Mil. Whole Shine Medical Technology Co's debt to equity for the quarter that ended in Mar. 2024 was 1.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Whole Shine Medical Technology Co's Debt-to-Equity or its related term are showing as below:

SZSE:002622' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.32 Max: 1.16
Current: 1.12

During the past 13 years, the highest Debt-to-Equity Ratio of Whole Shine Medical Technology Co was 1.16. The lowest was 0.00. And the median was 0.32.

SZSE:002622's Debt-to-Equity is ranked worse than
88.8% of 2626 companies
in the Industrial Products industry
Industry Median: 0.28 vs SZSE:002622: 1.12

Whole Shine Medical Technology Co Debt-to-Equity Historical Data

The historical data trend for Whole Shine Medical Technology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whole Shine Medical Technology Co Debt-to-Equity Chart

Whole Shine Medical Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.32

0.46

0.69

0.88

1.16

Whole Shine Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.92	0.87	0.83	1.16	1.12

Competitive Comparison of Whole Shine Medical Technology Co's Debt-to-Equity

For the Specialty Industrial Machinery subindustry, Whole Shine Medical Technology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Whole Shine Medical Technology Co's Debt-to-Equity Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Whole Shine Medical Technology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Whole Shine Medical Technology Co's Debt-to-Equity falls into.

Whole Shine Medical Technology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Whole Shine Medical Technology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(338.666	+	161.343)	/	432.784
	=	1.16

Whole Shine Medical Technology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(333.537	+	149.55)	/	431.543
	=	1.12

Whole Shine Medical Technology Co (SZSE:002622) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Whole Shine Medical Technology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Whole Shine Medical Technology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Whole Shine Medical Technology Co (SZSE:002622) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Whole Shine Medical Technology Co Ltd (SZSE:002622) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 98, Yingbin Road, Shiping District, Jilin Province, Jilin, CHN, 132013

Website

https://www.wholeshinemedical.com

Whole Shine Medical Technology Co Ltd is a China based company engaged in the businesses of electrical equipment, credit report big data, e-commerce big data, banking service, commercial factoring, financial leasing, and insurance brokerage service. In the electrical equipment business, the company offers electrical equipment products like Electronic control equipment, permanent magnet low-voltage switch products, permanent magnet high-voltage switch products, electronic energy meters, highway component facilities, and others.

Executives

Chen Ya Wei	Independent director
Ma Zheng Xue	Executives
Li Xiang Wen	Director
Huang Jia Hui	Directors, executives
Deng Qiang	Executives
Li Gang	Director
Lv Yong Xiang	Directors, executives
Zhao Feng	Directors, executives
Lv Lan	Secretary, Director

Whole Shine Medical Technology Co (SZSE:002622) Headlines

No Headlines